This Data Privacy Day, it’s time for a deep dive on your health privacy. #PrivacyAware 1/7
Patients have the right to their med records but getting their hands on it can involve jumping through hoops – it doesn’t have to. Patients have the right to their health data. HC providers must respond to requests for med records within 30 days. #PrivacyAware 2/7
The right to your medical info is set in a law called HIPAA. That’s with one ‘P’ – two Ps is for HIPPO. A hippo may be the world’s deadliest animal, but in most cases it has nothing to do with healthcare. @privacyrights explains your rights via privacyrights.org/consumer-guide….
Not-so-fun-fact: many consumers think the info collected by health apps is protected under the law. But in many cases, it’s not. Let’s get #PrivacyAware about where privacy rights exist and don’t exist. #PrivacyAware 4/7
More and more health tech is coming online and much of it is available directly to the consumer. Consumers should be able to take advantage of new health technology without giving up their privacy. So why isn’t that always the case? #PrivacyAware 5/7
And finally, it’s time to draw the line when it comes to employers getting into our business via wellness programs. Sometimes, the info collected in wellness programs is just TMI.
In our post, we detail the laudable advances put forward in the @AmerMedicalAssn's Privacy Principles, including principles on: increasing transparency, increasing health equity, and precautions against digital phenotyping. (2/4)
We also detail key differences between AMA's principles and HIPAA regulations. If you like comparison tables, you're in luck! We made a side-by-side comparison of the AMA Privacy Principles and HIPAA. (3/4) static1.squarespace.com/static/5be4eaf…
Wearables and in-home sensors offer great promise for affordable, accessible, equitable, high-quality care. But the data creates a safety issue that extends beyond the body. Want to learn more? Check out @GoldsackJen@_DiMeSociety and my latest blog bit.ly/2YeTcDL
Professional codes of ethics, laws, and regulations set patient privacy protections within healthcare. For good reason: patients should control access their health information.
But shaky data rights in the U.S. mean health tech could unwittingly putting patients' data at risk.
It’s time that data rights are central to our definition of “patient safety.” Specifically, we propose that patient safety in the digital era be redefined to include the risk of harm to individuals through digital health technologies and the data they generate.
Consumers feel like they have little control over data collected on them. Users of #reprohealth apps have reason to be wary. @ConsumerReports tested 5 apps and found shortcomings in the way all handle the sensitive user data they collect. cr.org/periodtrackers
Repro health apps are offered as an empowerment tool for consumers eager for power and agency over their health. Yet at the same time, many health apps do not have proper privacy standards in place, which too often results in sensitive health data falling into the wrong hands.
US privacy laws are a safety net with more gaps than coverage. Health privacy laws that consumers rely on to protect sensitive details abt themselves do not extend to health tech like repro health apps. The bar is low. As a purveyor of wellness, app developers should aim higher
Your regular reminder that HIPAA + other health privacy laws don’t apply to DTC genetic testing companies. When you take a test, you share your family genetic info. When you test your kid, you make a choice about their privacy that can't be undone when they're older.
.@CRAdvocacy supports @ab824, which would help ensure that the pathways for entry by affordable generic alternatives stay open, so that budget-conscious consumers will have choices, and will not have to continue paying unjust monopoly prices for the medications they need. 1/4
What we're talking about here is prohibiting anti-competitive "pay for delay" schemes, where brand-name prescription drug makers effectively pay-off makers of more affordable generic (or biosimilar) alternatives so the brand-name drug maker can prolong its monopoly profits. 2/4
.@ConsumerReports has covered the issue of Rx affordability many times over the years. This recent article re-confirmed that escalating Rx costs force many consumers to choose between cutting back on needed medications or on other basic necessities. consumerreports.org/drug-prices/ho… 3/4
Wellness programs are promoted as improving wellness, and they’re having a moment. But, they may not be a fair deal for enrollees. @ConsumerReports explains why wellness programs may not be all they appear. consumerreports.org/health-privacy…
Last year, 82% of larger companies & 53% of smaller firms offered some type of wellness program kff.org/health-costs/r…
But, problems lurk just below the surface of wellness programs.